Before your Sponsor can dose a single human volunteer, they must complete a rigorous gauntlet of preclinical studies that costs millions and takes years. From pharmacokinetics to multi-species toxicology, from formulation development to manufacturing scale-up, every step is governed by strict regulatory requirements. 

When you understand that the IND filing represents crossing a "sacred threshold" after years of scientific validation, you'll never again wonder why Sponsors react so strongly to protocol deviations or timeline delays. This isn't just another regulatory document. It's the culmination of their entire journey and the gateway to everything they've been working toward.